s6y
Company name or ticker
Search
Allogene Therapeutics, Inc.
4
Kazam Joshua A: Statement of changes in beneficial ownership of securities
Filed
Friday, January 14, 2022
Period
Jan 12, 2022
Accession number
0001214659-22-000706
Documents
PRIMARY DOCUMENT
4
On sec.gov
Filing index
All files
Complete submission text
SGML header